| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.06 |